【摘要】 目的探讨胺碘酮辅助常规对症支持干预治疗慢性心力衰竭合并糖尿病患者室性心律失常临床疗效。方法选取我院近期收治慢性心力衰竭合并糖尿病室性心律失常患者110例,采用随机数字表法分为对照组和观察组,每组各55例;其中对照组患者采用常规对症支持干预治疗,观察组患者则在此基础上加用胺碘酮口服治疗;比较两组患者心功能改善疗效,室性心律失常改善疗效及治疗前后室性心律失常发生情况等。结果观察组患者心功能改善疗效和室性心律失常改善疗效显著优于对照组(P<0.05);观察组患者治疗后室性心律失常发生情况显著优于对照组、治疗前(P>0.05)。结论胺碘酮辅助常规对症支持干预治疗慢性心力衰竭合并糖尿病患者室性心律失常可显著改善心脏功能,降低室性心律失常发生几率。更多还原

【Abstract】 Objective To investigate the clinical efficacy of routine symptomatic supporting intervention assisted by amiodarone on ventricular arrhythmia in patients with chronic heart failure complicated by diabetes. Methods A total of 110 patients with ventricular arrhythmia secondary to chronic heart failure complicated by diabetes treated in our hospital recently were selected, and divided into observation group and control group by the random digits table method,with 55 patients in each group. The patients of the control group were treated with routine symptomatic supporting intervention, while the patients of the observation group treated with oral amiodarone in addition to the routine symptomatic supporting intervention. The heart function improvement, ventricular arrhythmia improvement, and incidence of ventricular arrhythmia before and after treatment were compared between the two groups. Results The observation group had significantly better heart function improvement and ventricular arrhythmia improvement than the control group(P<0.05); the incidence of ventricular arrhythmia in the observation group after the treatment was significantly lower than that in the control group and before the treatment(P<0.05). Conclusion Routine symptomatic supporting intervention assisted by amiodarone in the treatment of ventricular arrhythmia in patients with chronic heart failure complicated by diabetes can significantly improve the heart function and reduce the incidence of ventricular arrhythmia.更多还原